Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T39741 |
SSAO inhibitor-1
|
||
SSAO inhibitor-1 is a compound that acts as an inhibitor of semicarbazide-sensitive amine oxidase (SSAO). It exhibits anti-inflammatory properties and is commonly employed in research pertaining to liver diseases. | |||
T60640 | SSAO inhibitor-2 | ||
SSAO inhibitor-2 (Compound 1) 可用于动脉粥样硬化、糖尿病及其并发症、肥胖、中风、慢性肾病、视网膜病变、慢性阻塞性肺病 (COPD)、自身免疫性疾病、多发性硬化等的研究。SSAO inhibitor-2 是氨基脲敏感性胺氧化酶 (SSAO) 抑制剂,其对人 SSAO 和 MAO-A 的IC50分别为 <10 nM 和 10-100 μM。 | |||
T60909 | SSAO inhibitor-3 | ||
SSAO inhibitor-3 (Compound 2) 可用于研究动脉粥样硬化、糖尿病及其并发症、肥胖症、中风、慢性肾病、视网膜病变、慢性阻塞性肺病 (COPD)、自身免疫性疾病、多发性硬化等。SSAO inhibitor-3 是一种氨基脲敏感性胺氧化酶 (SSAO) 的抑制剂,对人 AOC1 和SSAO 的IC50分别为 0.1-10 μM 和 <10 nM 。 | |||
T61133 |
SSAO/VAP-1 inhibitor 1
|
||
SSAO/VAP-1 inhibitor 1 是一种有效的SSAO/VAP-1抑制剂。SSAO/VAP-1 促进葡萄糖转运 4 (GLUT 4) 从脂肪细胞转移到细胞膜,从而调节葡萄糖转运。在内皮细胞中,SSAO/VAP-1 可以介导白细胞和内皮细胞的粘附和渗出,并参与炎症反应。SSAO/VAP-1 inhibitor 1 具有研究炎症和/或炎症相关疾病或糖尿病和/或糖尿病相关疾病的潜力。 | |||
T26795 |
PXS-4728A
BI-1467335,BI 1467335,BI1467335,BI-1467335 HCl |
Monoamine Oxidase | Neuroscience |
BI-1467335 HCl(BI 1467335) 是口服具有活性的、选择性的氨基脲敏感性胺氧化酶(SSAO) 抑制剂。PXS-4728A (BI 1467335) 能够改善小鼠的慢性阻塞性肺疾病。 | |||
T38966 |
PXS-4681A
|
||
PXS-4681A is a powerful, specific, and irreversible inhibitor of semicarbazide-sensitive amine oxidase (SSAO; VAP-1), with an oral activity and a Ki value of 37 nM. It exhibits exceptional selectivity towards related amine oxidases, ion channels, and seven-transmembrane domain receptors. Additionally, PXS-4681A demonstrates potent anti-inflammatory properties. | |||
T33265 |
MDL-72274 HCl
MDL 72274A,MDL72274,MDL-72274,MDL-72274A,MDL72274A,MDL 72274 |
||
MDL-72274 HCl is a selective and effective inhibitor of SSAO for the treatment of Parkinson's disease. | |||
T68785 | MD 220661 | ||
MD 220661 is an inhibitor of semicarbazide-sensitive amine oxidase (SSAO), and a substrate of the enzyme. |